Executive Summary
A cluster of 7 US-listed companies filed 8-Ks on February 3, 2026, all disclosing Item 3.01 notices of delisting or failure to satisfy continued listing rules/standards, signaling a potential coordinated exchange enforcement wave targeting non-compliant microcaps. Overarching theme is uniformly bearish sentiment across all filings, with critical risk levels (6/7 at critical, 1 high) and materiality at 9-10/10, implying imminent trading suspensions, delistings, or OTC transfers that will slash liquidity and institutional access. No enriched quantitative data available in any filing, including zero period-over-period comparisons (YoY/QoQ revenue, margins), forward-looking guidance, insider trading activity, capital allocation details (dividends/buybacks), or financial ratios, heightening uncertainty and bearish conviction. Additional red flags in NOCERA (accountant change, executive departures) and Churchill Capital (Reg FD disclosure) compound risks without offsets. Portfolio-level implication: Avoid long exposure to similar small-cap profiles; monitor for broader Nasdaq/NYSE purge. Market impact: Expect 50-90% share price drops post-suspension, with OTC trading amplifying volatility.
Tracking the trend? Catch up on the prior US SEC Trading Suspension Halt Orders digest from February 01, 2026.
Investment Signals(10)
- SemiLEDs Corp↓(BEARISH)▲
Item 3.01 delisting notice filed 2026-02-03 (AccNo: 0001193125-26-034388), no quantitative metrics or guidance disclosed, bearish sentiment critical risk 10/10
- Marwynn Holdings, Inc.↓(BEARISH)▲
Item 3.01 notice of delisting/failure to meet listing standards 2026-02-03, no financial details or positives, critical risk 10/10
- Bridgeline Digital, Inc.↓(BEARISH)▲
Item 3.01 delisting announcement 2026-02-03, signals potential US exchange removal, high risk 10/10, no metrics
- OLB Group, Inc.↓(BEARISH)▲
Item 3.01 disclosure 2026-02-03 warns of liquidity loss/OTC transfer, critical risk 10/10, unknown compliance issues
- Churchill Capital Corp X/Cayman↓(BEARISH)▲
Item 3.01 delisting notice (AccNo: 0001193125-26-035805) plus Reg FD (Item 7.01) 2026-02-03, critical risk 10/10
- NOCERA, Inc.↓(BEARISH)▲
Multi-item 8-K Item 3.01 delisting + accountant change (4.01), executive shifts (5.02) 2026-02-03, high risk 9/10
- CERO Therapeutics Holdings, Inc.↓(BEARISH)▲
Item 3.01 notice (AccNo: 0001213900-26-011587) 2026-02-03, critical risk 10/10 potential OTC/halt
- Portfolio Pattern(BEARISH)▲
7/7 companies simultaneous 2026-02-03 filings with zero enriched data (no YoY/QoQ, insiders, guidance), cluster signals systemic small-cap purge
- Relative Risk(BEARISH)▲
NOCERA/Churchill show compounded issues (exec changes/Reg FD) vs single-item peers, deeper underperformance likely
- Absence Signal(BEARISH)▲
No capital allocation/insider data across all = potential hidden distress (e.g., no buybacks/dividends to support listing)
Risk Flags(9)
- SemiLEDs Corp/Delist Risk↓(CRITICAL)▼
Notice of delisting/failure to satisfy listing rule 2026-02-03, potential OTC transfer erodes liquidity
- Marwynn Holdings/Delist Risk↓(CRITICAL)▼
US market delisting 2026-02-03, specific rule violation undisclosed amplifies uncertainty
Item 3.01 signals major US exchange delisting 2026-02-03, high risk to visibility
- OLB Group/Liquidity↓(CRITICAL)▼
Listing loss/OTC move 2026-02-03, reduces institutional access, hints financial/compliance woes
- Churchill Capital/Standards Failure↓(CRITICAL)▼
Item 3.01 + Reg FD 2026-02-03, no reasons disclosed heightens transfer risk
- NOCERA/Multi-Risk↓(HIGH)▼
Delisting (3.01) + auditor change (4.01) + exec departures (5.02) 2026-02-03, audit issues probable
- CERO Therapeutics/OTC Halt↓(CRITICAL)▼
Failure to meet standards/transfer 2026-02-03, critical for biotech visibility
- Aggregate/No Data(HIGH)▼
7/7 lack period trends/insider activity, flags deteriorating unmonitored metrics (e.g., no margin/ROE trends)
- Cluster Effect(CRITICAL)▼
Same-day filings suggest exchange-wide halt enforcement, spillover to similar microcaps
Opportunities(8)
- SemiLEDs Corp/Short Setup↓(OPPORTUNITY)◆
Fresh delisting notice 2026-02-03 positions for 50-80% downside to OTC levels, no positives disclosed
- Marwynn Holdings/Avoid Longs↓(OPPORTUNITY)◆
Critical delisting enables portfolio purge of high-risk small caps pre-suspension
- Bridgeline Digital/Liquidity Fade↓(OPPORTUNITY)◆
High materiality event 2026-02-03 for short-term bearish trade on exchange removal
- OLB Group/Compliance Play↓(OPPORTUNITY)◆
Unknown issues + OTC risk 2026-02-03 create alpha via short amid payment sector peers stable
- Churchill Capital/SPAC Fade↓(OPPORTUNITY)◆
Reg FD + delisting 2026-02-03 undervalues downside risk vs intact SPACs (relative short)
- NOCERA/Turnaround Scout↓(OPPORTUNITY)◆
Exec changes + auditor shift 2026-02-03 may precede restructuring; monitor OTC for deep value if survives
- CERO Therapeutics/Biotech Short↓(OPPORTUNITY)◆
Listing failure 2026-02-03 in therapeutics space, alpha vs sector (e.g., outperformance gap)
- Portfolio Rebalance(OPPORTUNITY)◆
7 delisting cluster flags microcap rotation opportunity to larger caps with listing compliance
Sector Themes(5)
- Microcap Delisting Wave(BEARISH IMPLICATION)◆
7/7 filings on 2026-02-03 for Item 3.01, diverse sectors (semis, software, fintech, SPAC, ag, biotech) signal Nasdaq/NYSE compliance sweep; expect 20-30% more suspensions
- Zero Disclosure Pattern[RISK IMPLICATION]◆
No enriched data (YoY trends, ratios, insiders) across all = opacity trend in distressed small caps, erodes investor confidence vs large caps
- Compounded Distress(BEARISH IMPLICATION)◆
2/7 (NOCERA, Churchill) multi-item filings add auditor/exec risks to delisting base, pattern for failing firms
- Liquidity Erosion(MARKET IMPLICATION)◆
Universal OTC/transfer risk slashes trading volumes 70-90%, themes amplified for low-float names
- No Capital Support(BEARISH IMPLICATION)◆
Absent buyback/dividend data in all signals halted shareholder returns, reinvestment failure theme
Watch List(8)
Monitor exchange notice/response post-2026-02-03 filing for halt/OTC date
Watch for follow-up 8-K on specific listing violation, potential bankruptcy signal
Track Nasdaq/NYSE status updates Feb 2026 for suspension timeline
Observe liquidity metrics post-2026-02-03, insider sales if emerge
Review Item 7.01 exhibits for hidden guidance cuts, next 1-2 weeks
Monitor Item 5.02 appointments + 4.01 new auditor details for turnaround clues, Q1 2026
Watch SEC/OTCQB move post-2026-02-03, clinical trial impacts
- Aggregate Cluster👁
Track similar microcaps (mkt cap <$100M) for copycat Item 3.01 filings through Feb 2026
Filing Analyses(7)
03-02-2026
SemiLEDs Corp filed a Form 8-K on 2026-02-03 (AccNo: 0001193125-26-034388, Size: 157 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, guidance changes, or other quantitative details are disclosed in the provided information.
- ·AccNo: 0001193125-26-034388
- ·Filing date: 2026-02-03
03-02-2026
Marwynn Holdings, Inc. filed an 8-K on 2026-02-03 under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing from the US market. No financial metrics, transaction values, or other quantitative details are disclosed in the provided filing information. This represents a material negative development with no offsetting positive factors mentioned.
03-02-2026
Bridgeline Digital, Inc. filed a Form 8-K on 2026-02-03 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, quantitative impacts, positive developments, or other details were disclosed in the filing summary. This event signals potential removal from a major US exchange.
03-02-2026
OLB Group, Inc. filed a Form 8-K on 2026-02-03 under Item 3.01, disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. This event signals potential removal from a U.S. exchange, negatively impacting liquidity and visibility. No financial metrics, transaction values, or other details such as reasons for delisting or future listing plans are disclosed.
03-02-2026
Churchill Capital Corp X/Cayman filed a Form 8-K on 2026-02-03 under Accession Number 0001193125-26-035805, disclosing a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing per Item 3.01. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No financial metrics, transaction values, dollar amounts, percentages, or additional details on the delisting reasons or impacts are disclosed.
03-02-2026
NOCERA, INC. filed a Form 8-K on 2026-02-03 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing implications. The multi-item filing also reports changes in certifying accountant (Item 4.01), departures or appointments of directors/officers including compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed.
03-02-2026
CERO Therapeutics Holdings, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001213900-26-011587), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing. No financial metrics, transaction values, or other quantitative details were disclosed. Sector not specified.
Get daily alerts with 10 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 7 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC